2021 CMSC Annual Meeting

Tag: 7080DMT60Poster-Disease-modifying TherapyRadmila Karan

Poster-Disease-modifying Therapy

Clinical Outcomes in Patients with COVID-19 Infection during Phase IV Studies of Cladribine Tablets for Treatment of Multiple Sclerosis

Background: The COVID-19 pandemic has become a significant concern for patients with multiple sclerosis (MS) and their healthcare...

Read More